Table 5 Subgroup analysis of the estimated global prevalence of FSD in women with hidradenitis suppurativa
Subgroups | Number Studies | Point estimate | Lower limit | Upper limit | P-value | P-value between | I2 (%) | Tau | |
|---|---|---|---|---|---|---|---|---|---|
Location | Africa | 1 | 0.667 | 0.333 | 0.889 | 0.327 | 0.292 | 0.00 | 0.00 |
America | 1 | 0.667 | 0.518 | 0.788 | 0.028 | 0.000 | 0.00 | ||
Europe | 3 | 0.533 | 0.43 | 0.633 | 0.529 | 0.095 | 0.308 | ||
Tools | FSFI | 2 | 0.621 | 0.559 | 0.68 | 0.00 | 0.179 | 0.00 | 0.00 |
FSFI-6 | 3 | 0.53 | 0.41 | 0.646 | 0.627 | 0.116 | 0.34 | ||